Intractable Pain with Lung Cancer
Overview
Authors
Affiliations
This study examines retrospectively the natural history, classification, clinical and pathological features and results of treatment of intractable pain associated with lung cancer in 221 patients. The 3 chief causes of malignancy-related pain were skeletal metastatic disease (34%), Pancoast's tumour (31%) and chest wall disease (21%), together comprising 78% of the cancer-related pain problems. The median interval between cancer diagnosis and pain onset was 1 month. Overall pathological types of cancer were similar to those of lung cancer in general. Treatment modalities were varied and included radiation, percutaneous cordotomy, regional deafferentation and pharmacotherapy. The median survival from pain onset was 10 months.
Pain Quality by Location in Outpatients with Cancer.
Schlaeger J, Weng L, Huang H, Tsai H, Takayama M, Ngamkham S Pain Manag Nurs. 2019; 20(5):425-431.
PMID: 31160180 PMC: 6875614. DOI: 10.1016/j.pmn.2019.04.007.
Pancoast's syndrome caused by lymph node metastasis from breast cancer.
Di Stefano V, Valdesi C, Zilli M, Peri M BMJ Case Rep. 2018; 11(1).
PMID: 30567112 PMC: 6301591. DOI: 10.1136/bcr-2018-226793.
Oxycodone Resistance Due to Rifampin Use in an Osteosarcoma Patient with Tuberculosis.
Sakamoto A, Yamashita M, Hori Y, Okamoto T, Shimizu A, Matsuda S Am J Case Rep. 2017; 18:1130-1134.
PMID: 29061956 PMC: 5665608. DOI: 10.12659/ajcr.905637.
Clinical management of pain in advanced lung cancer.
Simmons C, MacLeod N, Laird B Clin Med Insights Oncol. 2012; 6:331-46.
PMID: 23115483 PMC: 3474460. DOI: 10.4137/CMO.S8360.
Management of common symptoms of advanced lung cancer.
Bedor M, Alexander C, Edelman M Curr Treat Options Oncol. 2004; 6(1):61-8.
PMID: 15610715 DOI: 10.1007/s11864-005-0013-2.